Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

23.50p
   
  • Change Today:
      0.25p
  • 52 Week High: 71.31
  • 52 Week Low: 12.00
  • Currency: UK Pounds
  • Shares Issued: 92.53m
  • Volume: 198,099
  • Market Cap: 21.75m
  • RiskGrade: 747

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-21 Interim n/a (2.81) (3.00)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 2.62 (7.58) (35.36)p n/a n/a n/a n/a 0.0%
30-Jun-18 1.94 (7.79) (37.24)p n/a n/a n/a n/a 0.0%
30-Jun-19 2.36 (4.52) (13.87)p n/a n/a n/a n/a 0.0%
30-Jun-20 1.06 (20.38) (54.48)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.69 (1.85) (1.19)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 n/a n/a n/a n/a n/a n/a n/a 0.0%
30-Jun-23 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genedrive Market Data

Currency UK Pounds
Share Price 23.50p
Change Today 0.25p
% Change 1.08 %
52 Week High 71.31
52 Week Low 12.00
Volume 198,099
Shares Issued 92.53m
Market Cap 21.75m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.67% below the market average37.67% below the market average37.67% below the market average37.67% below the market average37.67% below the market average
64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average
Price Trend
47.68% below the market average47.68% below the market average47.68% below the market average47.68% below the market average47.68% below the market average
21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average
Income Not Available
Growth
59.61% below the market average59.61% below the market average59.61% below the market average59.61% below the market average59.61% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Genedrive Dividends

No dividends found

Trades for 23-May-2022

Time Volume / Share Price
11:45 10,000 @ 23.20p
11:45 30,000 @ 23.20p
11:44 1,516 @ 23.20p
11:40 3,000 @ 23.20p
11:37 17,205 @ 23.25p

Genedrive Key Personnel

CEO David Budd
CFO Russell Shaw

Top of Page